• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 1
  3. Author

Online ISSN: 2515-8260

Volume10, Issue1

ROLE OF 68 Ga DOTA NOC PET/CT IN INITIAL EVALUATION, IMPACT ON MANAGEMENT AND ITS INCREMENTAL VALUE IN EVALUATION OF NET; SINGLE INSTITUTIONAL STUDY

    Saroj Kumar Sahu, Sudatta Ray

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 1, Pages 3809-3813

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Neuroendocrine tumours (NETs) are rare, heterogeneous group of tumours which usually originate from small, occult primary sites and are characterized by over-expression of somatostatin receptors (SSTRs). Positron emission tomography/computed tomography (PET/CT) using Ga-68-labeled-somatostatin-analogues have shown superiority over other modalities for imaging of NETs. The objective of the study was to retrospectively evaluate the efficacy of Ga-68 DOTANOC PET/CT imaging in detecting the primary site in patients with metastatic NETs of unknown origin and its impact on clinical decision making in such patients
Keywords:
  • PDF (501 K)
  • XML
(2023). ROLE OF 68 Ga DOTA NOC PET/CT IN INITIAL EVALUATION, IMPACT ON MANAGEMENT AND ITS INCREMENTAL VALUE IN EVALUATION OF NET; SINGLE INSTITUTIONAL STUDY. European Journal of Molecular & Clinical Medicine, 10(1), 3809-3813.
Saroj Kumar Sahu, Sudatta Ray. "ROLE OF 68 Ga DOTA NOC PET/CT IN INITIAL EVALUATION, IMPACT ON MANAGEMENT AND ITS INCREMENTAL VALUE IN EVALUATION OF NET; SINGLE INSTITUTIONAL STUDY". European Journal of Molecular & Clinical Medicine, 10, 1, 2023, 3809-3813.
(2023). 'ROLE OF 68 Ga DOTA NOC PET/CT IN INITIAL EVALUATION, IMPACT ON MANAGEMENT AND ITS INCREMENTAL VALUE IN EVALUATION OF NET; SINGLE INSTITUTIONAL STUDY', European Journal of Molecular & Clinical Medicine, 10(1), pp. 3809-3813.
ROLE OF 68 Ga DOTA NOC PET/CT IN INITIAL EVALUATION, IMPACT ON MANAGEMENT AND ITS INCREMENTAL VALUE IN EVALUATION OF NET; SINGLE INSTITUTIONAL STUDY. European Journal of Molecular & Clinical Medicine, 2023; 10(1): 3809-3813.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 3
  • PDF Download: 3
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus